Justin Levisay to Humans
This is a "connection" page, showing publications Justin Levisay has written about Humans.
Connection Strength
0.172
-
Balloon Aortic Valvuloplasty Followed by Impella®-Assisted Left Main Coronary Artery Percutaneous Coronary Intervention in Patients With Severe Aortic Stenosis as a Bridge to Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2021 01; 22:16-21.
Score: 0.025
-
Percutaneous vascular plug for incomplete surgical left atrial appendage closure. J Invasive Cardiol. 2014 Apr; 26(4):180-2.
Score: 0.016
-
Antegrade approach for TAVR with total occlusion of the descending aorta. Catheter Cardiovasc Interv. 2014 Apr 01; 83(5):824-30.
Score: 0.016
-
Longer-term outcomes of paclitaxel stent implantation as an initial treatment strategy for sirolimus-eluting stent restenosis. J Invasive Cardiol. 2010 May; 22(5):216-9.
Score: 0.012
-
Coronary artery aneurysm formation after drug-eluting stent implantation. Cardiovasc Revasc Med. 2008 Oct-Dec; 9(4):284-7.
Score: 0.011
-
Unrecognized stent embolization causing recurrent chest pain. J Invasive Cardiol. 2006 Jan; 18(1):E74-5.
Score: 0.009
-
Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study. J Med Internet Res. 2023 11 10; 25:e47475.
Score: 0.008
-
Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance. J Am Heart Assoc. 2023 07 04; 12(13):e027851.
Score: 0.008
-
Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. Catheter Cardiovasc Interv. 2023 07; 102(1):145-154.
Score: 0.008
-
A Case of Valve-in-Valve-in-Valve for Severe Aortic Regurgitation: Is Lifetime Management Upon Us? Cardiovasc Revasc Med. 2023 08; 53S:S180-S183.
Score: 0.007
-
2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study. JACC Cardiovasc Interv. 2021 07 26; 14(14):1538-1548.
Score: 0.007
-
Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021. Trends Cardiovasc Med. 2021 04; 31(3):135-140.
Score: 0.006
-
1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study. JACC Cardiovasc Interv. 2020 10 26; 13(20):2344-2357.
Score: 0.006
-
Arterial Cutaneous Femoral Fistulous Tract Closure Using Surgiflo Hemostatic Matrix: A Novel Adjunct for Post-TAVR Access-Site Management. J Invasive Cardiol. 2017 Aug; 29(8):277-279.
Score: 0.005
-
Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care. Catheter Cardiovasc Interv. 2018 09 01; 92(3):E185-E196.
Score: 0.005
-
Drug-Coated Balloon Venoplasty for In-Stent Restenosis in a Patient With Recurrent Pulmonary Vein Stenosis Post Ablation for Atrial Fibrillation: Initial Experience With a New Treatment Technique. J Invasive Cardiol. 2016 May; 28(5):E44-8.
Score: 0.005
-
MitraClip Therapy for Mitral Regurgitation: Secondary Mitral Regurgitation. Interv Cardiol Clin. 2016 01; 5(1):83-91.
Score: 0.005
-
Low profile vascular plugs for paravalvular leaks after TAVR. Catheter Cardiovasc Interv. 2014 Feb; 83(2):280-8.
Score: 0.004
-
High pacing rates for management of aortic insufficiency after balloon aortic valvuloplasty or transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014 Jan 01; 83(1):162-8.
Score: 0.004
-
Fluoroscopically-guided micropuncture femoral artery access for large-caliber sheath insertion. J Invasive Cardiol. 2011 Apr; 23(4):157-61.
Score: 0.003
-
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J. 2008 Apr; 29(8):992-1000.
Score: 0.003